In 2023, she was awarded the top 50 most influential leaders in Pharmacy award presented by the Pharmacy Podcast network
Reduced Risk of Major Cardiovascular Events Clinical trials, such as the SUSTAIN-6 and PIONEER-6 studies, have demonstrated that Semaglutide can reduce the risk of major cardiovascular events, such as heart attack, stroke, and cardiovascular-related death
Nevertheless, these studys findings are significant, as they demonstrate that once-weekly semaglutide for patients with heart failure with preserved ejection fraction can lead to significant improvements in exercise and weight loss as well as reductions in heart failure-related symptoms
Orally administered glutathione, such as capsules and tablets, is typically poorly absorbed
Semaglutide is a prescription medication used to help people manage their weight
IGF-1 IGF 1 refers to Insulin-Like Growth Factor, a natural hormone found in the body working in close relation to natural Growth Hormone production